At 12p this looks a great BUY.Remember after the deal with Suvair this shot to around 30p ! Next news I am sure will be the announcement of some major deals.Fill up at this level.

Gn, Agree that the Nightingale part is too small and therefore would need an acquisition to give the business the critical mass if you cleaned out the traditional manufacturing part. But that is what would help revitalise this business and I would hope that is what the mgt will do. Seems to have been higher volume, early on almost all was buying. Was it tipped somewhere? IC did refer to it some 4 weeks ago so maybe they'll return to it this Friday?

Shares magazine's article on MRSA and the companies which might benefit omitted ETQ. Surprising given the trial of its equipment at Basingstoke hospital. Maybe it is a money issue for the government: being sued for dereliction of duty versus capital costs of taking appropriate measures? If the NHS ever gets to funding measures for prevention of this problem then ETQ should be well up the queue to benefit.

Shares magazine's article on MRSA and the companies which might benefit omitted ETQ. Surprising given the trial of its equipment at Basingstoke hospital. Maybe it is a money issue for the government: being sued for dereliction of duty versus capital costs of taking appropriate measures? If the NHS ever gets to funding measures for prevention of this problem then ETQ should be well up the queue to benefit.

up again today and breaking through the 3p bid level. others on ample are suggesting stories that the factories are working overtime on orders, though for which producrts is not clear...something seems to be changing.

i was introduced to this company through shares magazine some three years ago......maybe they were also let down by its progress.

nightingale should be seen as a wide range solution to airborne pathogens and not solely as a mrsa related product....all hospitals should have them at least for isolation wards....


GN

GN : They also need units in offices, factories, mail sorting offices etc plus a lighter version of Nightingales on aircraft to make spraying passengers with aerosols a thing of the past. Overriding all this is in my view a need for an acquisition of a larger company, possibly inheriting some of its mgt. as apart from the CEO, I think there is little depth/range in capabilities within the existing company. Pretty sure their new advisors will tumble to this fairly fast if they haven't already. The sp rise and increased volume suggests someone knows something.
As for Shares mag. not picking up on them, that is not a surprise given their current focus; I think the mag. is changing and not all of those changes are improvements.

Just read this from another board.
http://myweb.tiscali.co.uk/superbug/
cyril

noc, very relevant link. The NHS just seem happy to ignore airborne pathogens as a cause because the government doesn't want to spend the money. Maybe the activity around ETQ means some progress is being made. Not before time.

http://www.britishbulls.com/StockPage.asp?CompanyTicker=ETQ&MarketTicker=INDUSTRIALS&Typ=S

akel,

an interesting site, I just had a good look through and wanted to know have you been using it or following its advice for long? how would you rate it? cheers

gn

Something is definately bubbling under the surface.....this could be about to take off. Sells are out-numbering buys 3 to 1 today, yet it has continued to climb. It is being traded well above average, perhaps the MM are offering a low spread to increase sells in order to collect stock / fill an order as they now something we dont......watch this one to could be ready!!

RobRocket, A contact I have who is close to them reckons that the sale of the traditional business and retention of the Nightingale/Lifebreath part where there have been some large orders + a possible acquisition is a distinct possibility. Doubt it will be long before we find out.

Global Nomad
to tell you the truth i really do not rate it
i just go there out of interest, and all they do is follow the trends
you can really come unstuck if you follow them willy-nilly
its like anything else i suppose,nothing better than research,
the real reason for the rise is the two page write up in shares mag about superbugs this week,"no etq were not mentioned" but they have the product to fight them,

also by coincidence its about 1 year ago "july" that the price doubled

and then again it might even be results are just around the corner
and some one knows a thing or two, "take your pick"

This share has got to be undervalued. ETQ's core business seems on the up what with more staff and larger premises. Also the SP was valued far higher than this prior to the nightingale product and now the core of their business is doing better than it was before the nightingale. With or without the nightingale the 3p mark is well off the mark.
I got into this because some of my patients developed complications of MRSA and as a health care worker I know that it is impossible to barrier nurse someone effectively unless the air is decontaminated. This cannot be done by fumigation because you would have to close down a ward and evacuate all the patients and staff to carry this process out. ETQ's solution is a good one, all it requires is recognition and acceptance. I believe that a version of the product should be available to Virgin airlines British Airways GP rooms, basically anywhere that people meet and have the potential to contaminate each other, I feel concerned regarding other conditions such as SARS. I look forward to ETQ's results.

Gidruth, Interesting comment. The Basingstoke Hospital trial must be concluded soon; IMO the NHS is taking alot of suppliers for a ride, free trials and then loads of red tape before the gov. release any money. I think the mgt must be nearing making an announcement from my contacts there.

I've posted this on Adven's free BB as well. I think that what the NHS have yet to realise is that Hospitals have enjoyed a period of successful antibiotic treatment for their patients. As such, previously if someone developed an infection within the hospital environment, (such as MRSA), routine hygiene methods plus antibiotic therapy worked together effectively to reduce cross infection. Now that antibiotics no longer have the same impact, it has taken away a vital part of the cross infection defence system. Simply washing more is good but it will not be enough. That's why I like the Nightingale product.
A hospital ward is a bit like a fish tank, its a closed environment. Unless someone changes the water in the fish tank, sooner or later unwanted bacteria will grow. With the ward it's the same, unless someone changes the air in the ward to a pathogen neutral zone it too will start to develop unwanted bacteria.
As said before the NHS has got away with it for this long because of antibiotic treatment, they no longer have that luxuary.
The NHS has a long history of being slow on the uptake for new products. Penicillin was used in American hospitals well before it was introduced into British hospitals at the cost of many lives.
The good thing is that once the NHS accept that something works they tend to use it all the time. As such if the Nightingale proves itself to be efficient against the cross infection fight within the clinical arena, they will introduce them into hospitals. As such there is still a great potential for the nightingale product.

nice to have you join us with your insights Gidruth

Thanks Global Nomad.
The good thing about this share is that it is an 'ethical buy'. People are presently suffering and dying due to conditions such as MRSA. This product could prevent this from happening. It can help prevent it without the use of invasive drugs, that no longer work anyway.
Lets clean our Hospitals up and start saving lives !

Quite a lot of buys going through today, no sells. I wonder if someone knows something about the results that are due ?